Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001176256-08-000147
Filing Date
2008-02-08
Accepted
2008-02-08 18:18:30
Documents
1
Period of Report
2008-02-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5640
  Complete submission text file 0001176256-08-000147.txt   7617
Mailing Address 6190 AGRONOMY ROAD, SUITE 405 VANCOUVER A1 V6T 1Z3
Business Address 6190 AGRONOMY ROAD, SUITE 405 VANCOUVER A1 V6T 1Z3 604-8220301
CHEMOKINE THERAPEUTICS CORP (Issuer) CIK: 0001092959 (see all company filings)

EIN.: 330921251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2236 EAST MALL, SUITE 208 UNIVERSITY OF BRITISH COLUMBIA VANCOUVER A1 V6T 1Z3
Business Address (604) 822-0304
Salari Hassan (Reporting) CIK: 0001294506 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51080 | Film No.: 08590685